Home › Stocks › DYN › All Fund Holders
DYN — DYNE THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 42 · Reported value held: $1.52B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 12.40M | $275.50M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 11.21M | $248.91M | 0.01% | Add |
| Janus Henderson Group history | Q1 2026 | 13.65M | $247.43M | 0.12% | Reduce |
| Vanguard Group history | Q4 2025 | 11.22M | $219.38M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 3.74M | $83.16M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 3.15M | $67.15M | 0.01% | New |
| Bank of America Corp history | Q2 2026 | 2.23M | $49.60M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 2.16M | $47.91M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 2.03M | $45.10M | 0.01% | Add |
| Marshall Wace history | Q2 2026 | 1.49M | $33.07M | 0.03% | Add |
| Northern Trust Corp history | Q2 2026 | 1.28M | $28.39M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.20M | $26.70M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 1.19M | $26.37M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 746.20K | $16.57M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 443.28K | $9.85M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 431.85K | $9.59M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 409.80K | $9.10M | 0.00% | Add |
| Balyasny Asset Management history | Q4 2025 | 432.99K | $8.47M | 0.01% | New |
| Renaissance Technologies history | Q2 2026 | 360.57K | $8.01M | 0.01% | Reduce |
| Moore Capital Management history | Q2 2026 | 305.79K | $6.79M | 0.11% | Add |
| Point72 Asset Management history | Q4 2025 | 329.35K | $6.44M | 0.01% | Reduce |
| CPP Investments history | Q4 2025 | 284.00K | $5.56M | 0.00% | Hold |
| Hillhouse Capital (HHLR Advisors) history | Q1 2023 | 478.40K | $5.51M | 0.10% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 242.39K | $5.38M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 220.66K | $4.90M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 187.91K | $4.17M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 164.60K | $3.66M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 97.94K | $2.18M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 84.05K | $1.87M | 0.00% | Hold |
| Manulife Financial history | Q2 2026 | 78.62K | $1.75M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 60.16K | $1.34M | 0.00% | New |
| Harvard Management Company history | Q1 2023 | 107.25K | $1.24M | 0.13% | Hold |
| Wellington Management Group history | Q2 2026 | 52.43K | $1.16M | 0.00% | Add |
| Norges Bank Investment Management history | Q2 2026 | 49.32K | $1.10M | 0.00% | Hold |
| Casdin Capital history | Q1 2025 | 100.00K | $1.05M | 0.09% | New |
| Prudential Financial history | Q2 2026 | 22.48K | $499.28K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 14.18K | $314.89K | 0.00% | New |
| Principal Global Investors history | Q3 2024 | 7.50K | $269.29K | 0.00% | Reduce |
| Farallon Capital Management history | Q1 2026 | 10.00K | $181.30K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 3.94M | $87.44K | 0.01% | Add |
| PNC Financial Services history | Q2 2026 | 537 | $11.93K | 0.00% | Reduce |
| Amundi US history | Q1 2025 | 21 | $198 | 0.00% | Hold |